CCR10 | bioCADDIE Data Discovery Index
Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Displaying 8 of 8 results for "CCR10"
i
  1. 1,25 (OH)2 vitamin D3 induces expression of CCR10 and other genes BioProject

    ID: PRJNA98981

    Keywords: Transcriptome or Gene expression

    Access Type: download

  2. with 1,25 (OH)2 vitamin D3 induces expression of CCR10 and other genes... ArrayExpress

    ID: E-GEOD-6743

    Description: Human naive T cells from peripheral blood were cultured in 24 wells coated with anti-CD3 and anti-CD28 antibodies in the presence or absence of retino...

  3. with 1,25 (OH)2 vitamin D3 induces expression of CCR10 and other genes... OmicsDI

    ID: E-GEOD-6743

    Date Released: 05-02-2014

    Description: Human naive T cells from peripheral blood were cultured in 24 wells coated with anti-CD3 and anti-CD28 antibodies in the presence or absence of retino...

  4. Cutaneous Localization In Multiple Myeloma In The Context Of Bortezomib Resistance: How Myeloma Cells Escape From The Bone Marrow To The Skin? BioProject

    ID: PRJNA311150

    Keywords: Transcriptome or Gene expression

    Access Type: download

    dataset.description: n homing of MM cells could be related to the high CCR10 expression of at the diagnosis and relapse and the loss of CXCR4 surface expression across the progression of the disease in the contest of Bortezomib resistance. This data was further confirmed in a larger series of patients. Moreover, high expression of CD44, together with the down-regulation of CD54 and the lack of expression of CD56 by MM cells in the BM relapse with the re-acquisition of both antigens during the cutaneous relapse may be the mechanism that drives the escape from BM of PCs and their localization into the skin. Our data have identified a possible mechanism that drives the escape from BM of myeloma cells and their localization into the skin. Overall design: To investigate the genes differentially expressed in malignant plasma cells of a patient with relapsed refractory MM patient, who developed a cutaneous localization, we performed gene expression profiling using Affymetrix GeneChip analysis of plasma cells purified from the bone marrow aspirates at diagnosis and relapse....
  5. MicroRNA Profiling Analysis of Differences between the Melanoma of Young Adults and Older Adults BioProject

    ID: PRJNA120857

    Keywords: Transcriptome or Gene expression

    Access Type: download

    dataset.description: d potentially targeting the inflammatory receptor CCR10; Primary melanoma in young adult patients was characterized by the increased expression of hsa-miR-449a and decreased expression of hsa-miR146b, hsa-miR 214*. Among the miRs expressed at higher levels in control nevi, compared to adult or young adult melanoma, was hsa-miR 574-3p. Only 2 miRs distinguished adult from young adult-pediatric nevi, hsa-miR374a* and has-miR-566. MiR 30a* appeared to be a strong marker of differentiation in clinical stages I-II adult and pediatric melanoma, and could predict classification of melanoma tissue in the two age groups. Furthermore, lymph node status in the two age groups was characterized by the statistically significant expression of hsa-miR-30a* and hsa-miR-204 (F-test, p-value <0.001). Overall design: Archival paraffin blocks of melanocytic neoplasms studied at the University of Pittsburgh Cancer Institute (UPCI) were retrieved from the files of the Health Sciences Tissue Bank (HSTB) database and disbursed by UPCI HSTB according to UPCI-IRB regulations. Ten primary FFPE-tissues (including melanocytic neoplasms of uncertain biological potential) were obtained from two cohorts of patients respectively segregated according to age: Cohort A - > 60 years and Cohort B - <30 years and utilized for microRNA profiling. These two case cohorts were separated by at least 30 years, thereby representing an adequate basis for an intergenerational study. Additionally, 6 benign nevi were used as homologous controls (3 from adults and 3 from young adult patients, respectively). A total of 26 lesions (20 test specimens + 6 controls) were analyzed. Primary diagnostic workup and verification of the diagnosis of primary neoplasms was performed by two independent reference pathologists. Total RNA was isolated from all lesions from (at average) 30 5┬Ám secti...
  6. Immune Responses to Seasonal TIV 2010-2011 Influenza Vaccination in Humans (see companion study SDY396,SDY564) ImmPort

    ID: SDY224

    Description: To use system biology approaches to compare differences in immune responses to vaccine

    molecularEntity.name: Anti-CCR10 PE antibody
  7. Plasmablast response to inactivated and live attenuated influenza vaccines (TIV3/TIV3 ID) in 2012 ImmPort

    ID: SDY305

    Description: To study the plasmablast response to 2012 seasonal inactivated influenza vaccine

    molecularEntity.name: anti-human CCR10
  8. Plasmablast response to inactivated and live attenuated influenza vaccines (TIV3/TIV3 ID/LAIV) in 2011 ImmPort

    ID: SDY113

    Description: To study the plasmablast response to influenza vaccines

    molecularEntity.name: anti-human CCR10

Displaying 8 of 8 results for "CCR10"